Experienced in Irritable Bowel Syndrome (IBS)

Dr. Souheil Moussly

Internal Medicine
Ebenezer Medical Center Orlando Corp.
845 E Oak St, 
Kissimmee, FL 
Accepting New Patients
Experienced in Irritable Bowel Syndrome (IBS)
Ebenezer Medical Center Orlando Corp.
845 E Oak St, 
Kissimmee, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Souheil Moussly is a primary care provider, practicing in Internal Medicine in Kissimmee, Florida. Dr. Moussly is rated as an Experienced provider by MediFind in the treatment of Irritable Bowel Syndrome (IBS). His top areas of expertise are Enlarged Prostate (BPH), Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, and Hypertension. Dr. Moussly is currently accepting new patients.

His clinical research consists of participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Internal Medicine
Licenses
Internal Medicine in FL
Languages Spoken
English
Arabic
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Health First
  • HMO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 3 Less Insurance Carriers -

Locations

EBENEZER MEDICAL CENTER ORLANDO CORP.
845 E Oak St, Kissimmee, FL 34744

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)
Enrollment Status: Completed
Publish Date: October 14, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Open-Label Extension Study to Evaluate the Long Term Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis LUCENT 3
A Phase 3, Multicenter, Open-Label Extension Study to Evaluate the Long Term Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis LUCENT 3
Enrollment Status: Active_not_recruiting
Publish Date: October 10, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Enrollment Status: Completed
Publish Date: May 31, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Patients With Crohn's Disease
A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Patients With Crohn's Disease
Enrollment Status: Active_not_recruiting
Publish Date: April 18, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
Enrollment Status: Completed
Publish Date: December 27, 2024
Intervention Type: Drug
Study Drugs: Mirikizumab, Ustekinumab
Study Phase: Phase 3
View 4 Less Clinical Trials
Similar Doctors
Advanced in Irritable Bowel Syndrome (IBS)
Dr. Ian C. Boykin
Internal Medicine
Advanced in Irritable Bowel Syndrome (IBS)
Dr. Ian C. Boykin
Internal Medicine

Florida Department Of Health

7205 S George Blvd, 
Sebring, FL 
 (60.0 miles away)
863-382-6040
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Ian Boykin is a primary care provider, practicing in Internal Medicine in Sebring, Florida. Dr. Boykin is rated as a Distinguished provider by MediFind in the treatment of Irritable Bowel Syndrome (IBS). His top areas of expertise are Hypertension, Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, Endoscopy, and Gastrostomy. Dr. Boykin is currently accepting new patients.

Advanced in Irritable Bowel Syndrome (IBS)
Dr. Sergio L. Menendez-Aponte
Internal Medicine
Advanced in Irritable Bowel Syndrome (IBS)
Dr. Sergio L. Menendez-Aponte
Internal Medicine

Ability Health Services, Inc

1200 Lexington Green Ln, 
Sanford, FL 
 (35.5 miles away)
Experience:
44+ years
Languages Spoken:
English, French, Polish, Portuguese, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Sergio Menendez-Aponte is a primary care provider, practicing in Internal Medicine in Sanford, Florida. Dr. Menendez-Aponte has been practicing medicine for over 44 years and is rated as a Distinguished provider by MediFind in the treatment of Irritable Bowel Syndrome (IBS). His top areas of expertise are Vitamin D Deficiency, High Cholesterol, Hypothyroidism, Bone Graft, and Vertebroplasty. Dr. Menendez-Aponte is currently accepting new patients.

Experienced in Irritable Bowel Syndrome (IBS)
Dr. Yuhan Fu
Internal Medicine
Experienced in Irritable Bowel Syndrome (IBS)
Dr. Yuhan Fu
Internal Medicine

Osceola Surgical Associates LLC

806 W Oak St, 
Kissimmee, FL 
 (5.0 miles away)
407-483-3376
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Yuhan Fu is a primary care provider, practicing in Internal Medicine in Kissimmee, Florida. Dr. Fu is rated as an Advanced provider by MediFind in the treatment of Irritable Bowel Syndrome (IBS). Her top areas of expertise are Gastroparesis, Indigestion, Irritable Bowel Syndrome (IBS), Endoscopy, and Colonoscopy. Dr. Fu is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Moussly's expertise for a condition
ConditionClose
      View All 87 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile